PetVivo appoints Mike Eldred to board, expanding from seven to eight directors

PetVivo Holdings, Inc.

Board increased to eight directors, effective Sep 25, 2024; Eldred fills new seat.
Eldred served as president/CEO of Dechra Pharmaceutical's North American ops until June 2024.
At Dechra he built team to 250+ people and grew sales to £191.6 million.
Eldred is deemed independent under Exchange Act; no committee assignment yet.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mike Eldred

Director

PETV · PetVivo Holdings, Inc.

Effective: 2024-09-25
Filed: September 26, 2024, 7:59 PM ET

Effective as of September 25, 2024, the Board of Directors of PetVivo Holdings, Inc. (the “Company”) increased the size of the Board from seven directors to eight directors and appointed Mike Eldred as a member of the Board to fill the vacancy created by the increase in size of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Mike Eldred was appointed as Director at PetVivo Holdings, Inc..

Action: appointed
Role: Director

Exact text from the filing

Effective as of September 25, 2024, the Board of Directors of PetVivo Holdings, Inc. (the “Company”) increased the size of the Board from seven directors to eight directors and appointed Mike Eldred as a member of the Board to fill the vacancy created by the increase in size of the Board.

View on SEC.gov

PetVivo Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-038223

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.